药效评价Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
期刊:The Journal of pharmacology and experimental therapeutics发表年份:2007作者:Takuma Mihara; Kayoko Mihara; Junko Yarimizu; Yasuyuki Mitani; Ritsuko Matsuda; Hiroko Yamamoto; Satoshi Aoki; Atsushi Akahane; Akinori Iwashita; Nobuya Matsuoka
